Learn about emerging NEDD8-activating enzyme inhibitors in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).
Learn about emerging NEDD8-activating enzyme inhibitors in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).